Orbus Therapeutics, Inc.   Report issue

For profit Phase 3
Founded: Palo Alto CA United States (2012)
Status: No NME R&D (2012)

Organization Overview

First Clinical Trial
2016
NCT02796261
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now